A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis.

Publication Year: 2022

DOI:
10.1177/17534666211070133

PMCID:
PMC8921750

PMID:
35274585

Journal Information

Full Title: Ther Adv Respir Dis

Abbreviation: Ther Adv Respir Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This report is independent research funded by the National Institute for Health Research (NIHR; Research for Patient Benefit Programme, ‘A Prospective Pilot Study of Home Monitoring in Adults with Cystic Fibrosis (HOME-CF)’, PB-PG-0712-28104) and by an educational grant via the Gilead UK and Ireland Fellowship Programme. KLS is funded by the NIHR CLAHRC West Midlands initiative. This article presents independent research and the views expressed are those of the author(s) and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health."

Evidence found in paper:

"Trial registration The study protocol was registered with Clinicaltrials.gov (NCT02994706) on 16 July 2014 and published in a peer reviewed journal. Data from this trial has been presented in abstract form at the ECFS Conference in Lyon in September 2020."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025